That’s a good point. I wonder though whether they will be able to administer any medication solutions based on scan results at the scene or will it still need to be verified by Gold Standard approved scans before any intervention is offered. Maybe they will be able to apply for some sort of HDE after a period of time. Who knows. Imagine having a scan and then still having to suffer the delay during the trial due to it not being approved. This is a good question for Scott as I am not sure on this one.
Ann: EMVision Releases its FY25 Half Yearly Report, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.80 |
Change
0.010(0.56%) |
Mkt cap ! $153.9M | |||
| Open | High | Low | Value | Volume |
| $1.82 | $1.85 | $1.80 | $79.01K | 43.15K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 555 | $1.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.83 | 5200 | 1 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| EMV (ASX) Chart |